CLC Number:
| [1] Hui CK, Hui NK. A prospective study on the prevalence, extent of disease and outcome of eosinophilic gastroenteritis in patients presenting with lower abdominal symptoms[J]. Gut Liver, 2018, 12(3): 288-296. [2] Pesek RD, Reed CC, Muir AB, et al. Increasing rates of diagnosis, substantial cooccurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium[J]. Am J Gastroenterol, 2019,114(6):984-994. [3] Koutri E, Papadopoulou A. Eosinophilic Gastrointestinal Diseases in Childhood[J].Ann Nutr Metab, 2018,73(Suppl 4): 18-28. [4] Tagore S, Prashanth R, Krishna SY, et al. Eosinophilic gastroenteritis: diagnosis and clinical perspectives[J]. Clin Exp Gastroenterol, 2019,12: 239-253. doi: 10.2147/CEG.S173130. [5] Uppal V, Kreiger P, Kutsch E. Eosinophilic gastroenteritis and colitis: a comprehensive review[J]. Clin Rev Allergy Immunol, 2016, 50(2): 175-188. [6] Kinoshita Y, Ishimura N, Oshima N, et al. Recent progress in the research of eosiphilic esophagitis and gastroenteritis[J]. Digestion, 2016, 93(1): 7-12. [7] Kinoshita Y, Ishihara S. Eosinophilic gastroenteritis: epidemiology, diagnosis, and treatment[J]. Curr Opin Allergy Clin Immunol, 2020, 20(3): 311-315. [8] 中华医学会血液学分会白血病淋巴瘤学组.嗜酸粒细胞增多症诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2017,38(7):561-565. [9] 徐樨巍, 李东丹. 儿童嗜酸性粒细胞性胃肠炎的诊断与治疗进展[J]. 中华实用儿科临床杂志, 2018,33(7): 481-485. [10] de Matos Brasil AA, Bezerra LN, Bruno EL, et al. Eosinophilic gastroenteritis with malabsorption, acute intestinal obstruction, ascites and pleural effusion: a case report and review of literature[J]. Gastroenterology Res, 2013, 6(6): 233-236. [11] Liang M, Liwen Z, Bingfang C, et al. Eosinophilic gastroenteritis with multiple serous membrane effusion as the first sign: a case report and literature review[J]. J Int Med Res,2020,48(4):300060520917274. doi: 10.1177/0300060520917274. [12] Fonseka CL, Nanayakkara S, Singhapura SDAL, et al. Eosinophilic gastroenteritis with a relapsing and remitting course with presence of autoimmune antibodies[J]. Case Rep Med, 2020, 2020: 1745834. doi: 10.1155/2020/1745834. [13] Untersmayr E, Bakos N, Schöll I, et al. Antiulcer drugs promote IgE formation toward dietary antigens in adult patients[J]. FASEB J, 2005, 19(6): 656-658. [14] Yamada Y, Toki F, Yamamoto H, et al. Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis[J]. Allergol Int, 2015, 64(Suppl): S83-S85. [15] Grandinetti T, Biedermann L, Bussmann C, et al. Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab[J]. Dig Dis Sci, 2019, 64(8): 2231-2241. [16] Choi JS, Choi SJ, Lee KJ, et al. Clinical manifestations and treatment outcomes of eosinophilic gastroenteritis in children[J]. Pediatr Gastroenterol Hepatol Nutr, 2015, 18(4): 253-260. [17] Kim HP, Reed CC, Herfarth HH, et al. Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis[J]. Clin Gastroenterol Hepatol, 2018, 16(12): 1992-1994. [18] Walker MM, Potter M, Talley NJ. Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus[J]. Lancet Gastroenterol Hepatol, 2018, 3(4): 271-280. [19] Lucendo AJ, Serrano-Montalbán B, Arias á, et al. Effificacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis[J]. J Pediatr Gastroenterol Nutr, 2015, 61(1): 56-64. |
| [1] | . [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 118-119. |
| [2] | XUE Ning, GUO Qingwei. Clinical analysis of 32 cases of ingested super absorbent polymer balls in children [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 65-68. |
| [3] | FU Xiaoli, WEI Xuxia, XU Junjie, XUE Ning, ZHANG Le, CHEN Hongling. Autoimmune enteropathy in children: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2023, 61(9): 118-124. |
|
||
